Viewing Study NCT04083495

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 1:13 PM
Ignite Modification Date: 2026-03-01 @ 5:18 PM
Study NCT ID: NCT04083495
Status: RECRUITING
Last Update Posted: 2025-09-22
First Post: 2019-09-05
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: CD30 CAR for Relapsed/Refractory CD30+ T Cell Lymphoma
Sponsor: UNC Lineberger Comprehensive Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peripheral T Cell Lymphoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None lymphoma View
None CD30 View
None peripheral T cell lymphoma View